Giulio Francolini

2.6k total citations
120 papers, 1.3k citations indexed

About

Giulio Francolini is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, Giulio Francolini has authored 120 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pulmonary and Respiratory Medicine, 45 papers in Radiology, Nuclear Medicine and Imaging and 31 papers in Radiation. Recurrent topics in Giulio Francolini's work include Prostate Cancer Treatment and Research (43 papers), Prostate Cancer Diagnosis and Treatment (33 papers) and Advanced Radiotherapy Techniques (31 papers). Giulio Francolini is often cited by papers focused on Prostate Cancer Treatment and Research (43 papers), Prostate Cancer Diagnosis and Treatment (33 papers) and Advanced Radiotherapy Techniques (31 papers). Giulio Francolini collaborates with scholars based in Italy, United States and Netherlands. Giulio Francolini's co-authors include Lorenzo Livi, Isacco Desideri, Mauro Loi, Pierluigi Bonomo, Beatrice Detti, Icro Meattini, Daniela Greto, Carlotta Becherini, Gianluca Ingrosso and Filippo Alongi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Giulio Francolini

106 papers receiving 1.3k citations

Peers

Countries citing papers authored by Giulio Francolini

Since Specialization

Citations

This map shows the geographic impact of Giulio Francolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulio Francolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulio Francolini more than expected).

Fields of papers citing papers by Giulio Francolini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulio Francolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulio Francolini. The network helps show where Giulio Francolini may publish in the future.

Co-authorship network of co-authors of Giulio Francolini

This figure shows the co-authorship network connecting the top 25 collaborators of Giulio Francolini. A scholar is included among the top collaborators of Giulio Francolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulio Francolini. Giulio Francolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perirectal spacers in radiotherapy for prostate cancer – a systematic review and meta-analysis 2025 ·Współczesna Onkologia ·Marcin Miszczyk, (unknown), Giulio Francolini, (unknown), (unknown), (unknown), Tamás Fazekas, Akihiro Matsukawa, (unknown), Mikołaj Przydacz, Michael Leapman, Paweł Rajwa, (unknown), Shahrokh F. Shariat	0
2	PERSIAN trial: Early results from a randomized phase II trial testing apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer. 2025 ·Journal of Clinical Oncology ·Giulio Francolini, Vanessa Di Cataldo, (unknown), Saverio Caini, Alessio Bruni, (unknown), Matteo Augugliaro, Roberto Iacovelli, Luca Tagliaferri, Nicola Battelli, Gianluca Ingrosso, Angelo Porreca, Marco Trovò, Giuseppe Fornarini, Giuseppe Carlo Iorio, Alessia Guarneri, Michele Sisani, Lorenzo Antonuzzo, (unknown), Lorenzo Livi, (unknown)	3
3	World-wide oligometastatic prostate cancer (omPC) meta-analysis leveraging individual patient data (IPD) from randomized trials (WOLVERINE): An analysis from the X-MET collaboration. 2025 ·Journal of Clinical Oncology ·Chad Tang, Alexander D. Sherry, Hyunsoo Hwang, Giulio Francolini, (unknown), Phuoc T. Tran, Paul G. Corn, Ana M. Aparicio, Gabriele Simontacchi, Ana P. Kiess, Jarey H. Wang, Valérie Fonteyne, Renée Bultijnck, Robert Olson, Stephen Harrow, Ethan B. Ludmir, Pierre Blanchard, (unknown), David A. Palma, David E. Ost	9
4	Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors 2024 ·Cancers ·Viola Salvestrini, (unknown), Marco Banini, Mauro Loi, (unknown), Emanuela Olmetto, (unknown), (unknown), Giulio Francolini, Pierluigi Bonomo, (unknown), Isacco Desideri, (unknown), Daniele Giansanti, Vieri Scotti, (unknown)	1
5	455: Re-SBRT after previous definitive or salvage radiotherapy (RE-START). A study on behalf of AIRO 2024 ·Radiotherapy and Oncology ·Giulio Francolini, Fabio Matrone, (unknown), Giulia Marvaso, Barbara Alicja Jereczek‐Fossa, Liliana Belgioia, Elisa D’Angelo, Rosario Mazzola, Rossana Ingargiola, Antonella Fontana, Alberto Cacciola, (unknown), Marcin Miszczyk, (unknown), (unknown)	1
6	ARTO trial: Overall survival analysis from a randomized phase II trial testing the benefit of adding stereotactic body radiotherapy to abiraterone acetate in patients with oligometastatic castrate-resistant prostate cancer. 2024 ·Journal of Clinical Oncology ·Giulio Francolini, Vanessa Di Cataldo, (unknown), Beatrice Detti, Saverio Caini, Alessio Bruni, Gianluca Ingrosso, Rolando Maria D’Angelillo, A.R. Alitto, Matteo Augugliaro, Luca Triggiani, Silvana Parisi, Gaetano Facchini, Marco Banini, Gabriele Simontacchi, Isacco Desideri, Icro Meattini, Richard K. Valicenti, Lorenzo Livi	0
7	Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 2022 ·International Journal of Molecular Sciences ·Mauro Loi, (unknown), Michele Aquilano, Daniela Greto, C. Talamonti, Viola Salvestrini, Maria Elena Melica, (unknown), Giulio Francolini, Mariangela Sottili, Costanza Santini, Carlotta Becherini, Domenico Andrea Campanacci, Monica Mangoni, Lorenzo Livi	1
8	Clinical validation of an automatic atlas‐based segmentation tool for male pelvis CT images 2022 ·Journal of Applied Clinical Medical Physics ·M. Casati, (unknown), S. Calusi, L. Marrazzo, Gabriele Simontacchi, Vanessa Di Cataldo, Daniela Greto, Isacco Desideri, (unknown), Giulio Francolini, Lorenzo Livi, S. Pallotta	12
9	1369P Biochemical outcomes from ARTO trial (NCT03449719) a phase II randomized trial testing association between abiraterone acetate and stereotactic body radiation therapy in castrate-resistant prostate cancer patients 2022 ·Annals of Oncology ·Giulio Francolini, (unknown), Vanessa Di Cataldo, Saverio Caini, A.R. Alitto, Silvana Parisi, (unknown), Alessio Bruni, (unknown), Giorgia Timon, Andrea Gaetano Allegra, (unknown), Viola Salvestrini, (unknown), (unknown), Luca Visani, Carlotta Becherini, Isacco Desideri, Icro Meattini, Lorenzo Livi	1
10	Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 2021 ·Critical Reviews in Oncology/Hematology ·Giulio Francolini, Simona Borghesi, Sergio Fersino, Alessandro Magli, Barbara Alicja Jereczek‐Fossa, (unknown), Mimma Rizzo, Renzo Corvò, Giovanni Pappagallo, Stefano Arcangeli, Stefano Maria Magrini, Rolando Maria D’Angelillo	7
11	Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: A systematic review 2021 ·Critical Reviews in Oncology/Hematology ·Gianluca Ingrosso, Carlotta Becherini, Giulio Francolini, Andrea Lancia, (unknown), Saverio Caini, Maria Ausilia Teriaca, (unknown), Andrea Riccardo Filippi, Lorenzo Livi, Giuseppe Sanguineti, Cynthia Aristei, Beatrice Detti	10
12	Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 2021 ·Cancer Treatment and Research Communications ·Beatrice Detti, Gianluca Ingrosso, Carlotta Becherini, Andrea Lancia, Emanuela Olmetto, (unknown), (unknown), Maria Ausilia Teriaca, Giulio Francolini, Angela Sardaro, Cynthia Aristei, Andrea Riccardo Filippi, Giuseppe Sanguineti, Lorenzo Livi	9
13	Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I line treatment with abiraterone acetate (ARTO trial-NCT03449719) 2020 ·European Urology Open Science ·Giulio Francolini, (unknown), (unknown), Antonio Bruni, Giovanna Mantini, Stefano Pergolizzi, Paolo Borghetti, Rolando Maria D’Angelillo, Filippo Alongi, (unknown), Ciro Franzese, A. Tagliagambe, (unknown), Michele Aquilano, (unknown), Viola Salvestrini, Lucia Pia Ciccone, (unknown), Lorenzo Livi	3
14	Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 2020 ·Supportive Care in Cancer ·Isacco Desideri, Giulio Francolini, Lucia Pia Ciccone, (unknown), Viola Salvestrini, Michele Aquilano, Daniela Greto, Pierluigi Bonomo, Icro Meattini, Vieri Scotti, Silvia Scoccianti, Gabriele Simontacchi, Lorenzo Livi	17
15	Performance assessment of a new optimization system for robotic SBRT MLC-based plans 2020 ·Physica Medica ·S. Calusi, Raffaela Doro, Vanessa Di Cataldo, Samantha Cipressi, Giulio Francolini, I. Bonucci, Lorenzo Livi, Laura Masi	13
16	Efficacy and Tolerability of CyberKnife Stereotactic Robotic Radiotherapy for Primary or Secondary Orbital Lesions: A Single-Center Retrospective Experience 2019 ·Technology in Cancer Research & Treatment ·Isacco Desideri, Giulio Francolini, Giulio Alberto Carta, Vanessa Di Cataldo, Laura Masi, Icro Meattini, Pierluigi Bonomo, Mauro Loi, Daniela Greto, Luca Visani, Monica Lo Russo, Roberta Grassi, Maria Ausilia Teriaca, (unknown), Cosimo Nardi, Lorenzo Livi	1
17	Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 2019 ·European Journal of Cancer ·Lorenzo Livi, Vieri Scotti, Isacco Desideri, Calogero Saieva, (unknown), Giulio Francolini, Carlotta Becherini, Camilla Delli Paoli, Luca Visani, Viola Salvestrini, Maria Laura De Feo, Jacopo Nori, Marco Bernini, Luis Sanchez, Lorenzo Orzalesi, Simonetta Bianchi, Icro Meattini	13
18	Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience. 2019 ·Cancer Treatment and Research Communications ·Giulio Francolini, Isacco Desideri, Beatrice Detti, Vanessa Di Cataldo, Laura Masi, (unknown), Luca Visani, (unknown), (unknown), Monica Lo Russo, Mauro Loi, Lorenzo Livi	13
19	A Case Report Series of Renal Cell Carcinoma Patients Treated with Nivolumab and Radiotherapy 2018 ·Giulio Francolini, Donato Pezzulla, Beatrice Detti, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
20	Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 2018 ·Critical Reviews in Oncology/Hematology ·Giulio Francolini, Beatrice Detti, Gianluca Ingrosso, Isacco Desideri, Carlotta Becherini, Giulio Alberto Carta, Donato Pezzulla, (unknown), Luca Dominici, (unknown), Maria Ausilia Teriaca, Marta Bottero, Lorenzo Livi	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact